Acquired Immunity In Healthy Adults to Ward Off 2009 H1N1 Influenza

Healthy adults may have a level of protective immune memory that can blunt the severity of infection caused by the 2009 H1N1 influenza virus, according to a new study.

A new study has reported that healthy adults may have a level of protective immune memory to the swine flu virus. This, it claims, can blunt the severity of infection caused by the 2009 H1N1 influenza.

In the study, researchers showed that molecular similarities exist between the 2009 H1N1 influenza virus and other strains of seasonal H1N1 virus that have been circulating in the population since 1988.

Immunity to Current H1N1 Influenza Linked to Early Virus Exposure
Earlier exposure to the seasonal flu viruses provide people with some level of immunity to the 2009 H1N1 influenza virus, scientists at University of California, Davis, have found.

The results suggest that healthy adults may have a level of protective immune memory that can blunt the severity of infection caused by the 2009 H1N1 influenza virus.

Led by Dr. Bjoern Peters and Dr. Alessandro Sette of La Jolla Institute for Allergy and Immunology, Calif., the researchers examined molecular structures known to be recognized by the immune system-called epitopes-on 2009 H1N1 influenza and seasonal H1N1 viruses.

Viral epitopes are recognized by immune cells called B and T cells- B cells make antibodies that can bind to viruses, blocking infection, and T cells help to eliminate virus-infected cells.

Scientists Set To Launch Trial Test The Efficacy of H1N1 Influenza Vaccine In HIV-Infected Women
A trial to test the efficacy of 2009 H1N1 influenza vaccine in HIV-infected pregnant women has been launched by scientists.

The data gathered and reviewed from the scientific literature was deposited into the Immune Epitope Database and Analysis Resource supported by the National Institute of Allergy and Infectious Diseases (NIAID).

The researchers used the information to find that some viral epitopes are identical in both the 2009 and seasonal H1N1 viral strains.

Serious Ethical Challenges Societies May Confront Due To H1N1 Influenza Pandemic
According to a report the anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance.

Those epitopes that could be recognized by two subsets of T cells, called CD4 and CD8 T cells, are 41 percent and 69 percent identical, respectively.

Subsequent experiments using blood samples taken from healthy adults demonstrated that this level of T-cell epitope conservation might provide some protection and lessen flu severity in healthy adults infected with the 2009 H1N1 influenza virus.

Immune Response Strong as H1N1 Influenza Vaccines are Well Tolerated
Health experts in the US have revealed that early results from various clinical trials of 2009 H1N1 influenza vaccines in healthy adults seem to be quite encouraging.

Analysis of the database also found that among six viral surface epitopes that can bind antibody, thereby preventing infection, only one is conserved between 2009 and seasonal H1N1 viral strains.

The results suggest that healthy individuals may have immune memory that recognizes the 2009 H1N1 strain and therefore can mount some measure of an immune attack.

The findings may also help explain why the 2009 H1N1 influenza pandemic affects young children more severely than it does healthy older adults and also why two H1N1 vaccinations are needed to protect children ages nine years and under.

Source-ANI
TAN